{"type": "project", "title": "Neuracct", "logoImg": "bafkreib7n4rl2tbkq5ymtc6cbnwypmy7bkapxbvgoxnw64lft34yr6345u", "website": "https://neuracct.com", "bannerImg": "bafkreiggxh7gv3jtxsbuqxyxkm7jxu5uucamiblfxggfugph22zvxm6rry", "createdAt": 1721039153648, "credentials": {}, "description": "Neuracct is a Zuzalu spin-off project which officially took place in Eistein medical school's lab. It is the first brain tissue replacement company focusing on the R&D of lab grown ACC (anterior cingulate cortex, act as a bridge between cognition and emotion) tissue to reverse cognitive decline with age, as well as curing psychiatric diseases caused by damage and ACC related disorders.\n", "logoImgData": {}, "bannerImgData": {}}
Neuracct
Neuracct is a Zuzalu spin-off project which officially took place in Eistein medical school's lab. It is the first brain tissue replacement company focusing on the R&D of lab grown ACC (anterior cingulate cortex, act as a bridge between cognition and emotion) tissue to reverse cognitive decline with age, as well as curing psychiatric diseases caused by damage and ACC related disorders.

Neuracct